Study details
Enrolling now
Barrigel® PPRT Trial
Palette Life Sciences, Inc.
NCT IDNCT06496256ClinicalTrials.gov data as of Apr 2026
Target enrollment
84
Study length
about 3.2 years
Ages
18+
Sex
Male only
Locations
4 sites in MA, NJ, TX
About this study
This trial is testing if Barrigel can help protect the rectum from radiation damage during prostate cancer treatment. It involves using Barrigel to position the rectal wall away from the prostate, potentially reducing the amount of radiation delivered to the rectum.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use Barrigel
- 2.Use Transrectal Ultrasound
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low12%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Secondary: Expanded Prostate Cancer Index Composite (EPIC) Urinary QOL, Expanded Prostate Cancer Index Composite (EPIC) bowel QOL
Body systems
Oncology